. Safety and efficacy of methylphenidate for apathy in alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013 Aug;74(8):810-6. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. New Treatments for Alzheimer’s Behavioral Symptoms on Horizon

Therapeutics

  1. Methylphenidate